Jiani Cao1,2,3,4, Jun Wei2,3,4, Ranran Xu3

  • 1State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

概括

干细胞药物的监管政策对于促进再生医学的发展至关重要. 这次审查考察了中国.